-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Chronic Transfusion for Patients with Hemoglobinopathies

Program: Education Program
Session: Chronic Transfusion Support: Challenging Cases
Hematology Disease Topics & Pathways:
Biological, Diseases, Therapies, Hemoglobinopathies, Clinically relevant, transfusion
Monday, December 7, 2020, 11:25 AM-11:30 AM

Ashutosh Lal, MD

Hematology/Oncology, Children's Hospital & Research Center Oakland, Oakland, CA

Disclosures: Lal: Protagonist Therapeutics: Membership on an entity's Board of Directors or advisory committees, Research Funding; La Jolla Pharmaceutical Company: Research Funding; Celgene, BMS: Membership on an entity's Board of Directors or advisory committees, Research Funding; Terumo Corporation: Research Funding; Chiesi USA: Consultancy; Agios Pharmaceuticals: Consultancy; bluebird bio, Inc.: Research Funding; Novartis: Research Funding; Insight Magnetics: Research Funding.

See more of: Chronic Transfusion Support: Challenging Cases
See more of: Education Program
Previous Presentation | Next Presentation >>